Recent News

572 News Items found
Man holding an IUD
Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.
A collage of photos showing a zebrafish with GFP-labeled melanocytes, magnified GFP-labeled melanocytes, and hPSC-derived melanocytes growing in a dish.
Experiments with zebrafish and human pluripotent stem cells reveal the necessary ingredients, besides genetic mutations, that fuel the development of melanoma.
MSK scientists Margaret Callahan, Ronglai Shen, and Katherine Panageas
A blood-based test identifies patients in whom immunotherapy may ‘LAG.’
Scientist Gabriela Chiosis in her lab
In the Lab
Memorial Sloan Kettering researchers are studying how drugs that reverse malfunctioning proteins may treat disease.
Memorial Sloan Kettering surgeon Prasad Adusumilli
Q&A
A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
MSK radiologist Andreas Wibmer
People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.
Memorial Sloan Kettering immunologist Frederic Geissmann
Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.
Lung cancer has an uncanny ability to change its identity to resist drugs. Researchers are learning what drives these changes.
Group photo of researchers Michael Berger, Marc Ladanyi, Dana Tsui, Rose Brannon, Ryma Benayed, Ahmet Zehir, and David Klimstra.
Feature
MSK-ACCESS, a blood test that can detect mutations in 129 genes related to cancer, has already helped guide the treatment of more than 2,800 patients at MSK.
Physician-scientist Omar Abdel-Wahab
In the Lab
In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.